Sinonasal Tract and Nasopharyngeal Adenoid Cystic Carcinoma: A Clinicopathologic and Immunophenotypic Study of 86 Cases
Thompson, Lester D. R.
Ho, Ngoc J.
Foss, Robert D.
Wieneke, Jacqueline A.
Moskaluk, Christopher A.
Stelow, Edward B.
MetadataShow full item record
‘Primary sinonasal tract and nasopharyngeal adenoid cystic carcinomas (STACC) are uncommon tumors that are frequently misclassified, resulting in inappropriate clinical management. Eighty-six cases of STACC included 45 females and 41 males, aged 12–91 years (mean 54.4 years). Patients presented most frequently with obstructive symptoms (n = 54), followed by epistaxis (n = 23), auditory symptoms (n = 12), nerve symptoms (n = 11), nasal discharge (n = 11), and/or visual symptoms (n = 10), present for a mean of 18.2 months. The tumors involved the nasal cavity alone (n = 25), nasopharynx alone (n = 13), maxillary sinus alone (n = 4), or a combination of the nasal cavity and paranasal sinuses (n = 44), with a mean size of 3.7 cm. Patients presented equally between low and high stage disease: stage I and II (n = 42) or stage III and IV (n = 44) disease. Histologically, the tumors were invasive (bone: n = 66; neural: n = 47; lymphovascular: n = 33), composed of a variety of growth patterns, including cribriform (n = 33), tubular (n = 16), and solid (n = 9), although frequently a combination of these patterns was seen within a single tumor. Pleomorphism was mild with an intermediate N:C ratio in cells containing hyperchromatic nuclei. Reduplicated basement membrane and glycosaminoglycan material was commonly seen. Necrosis (n = 16) and atypical mitotic figures (n = 11) were infrequently present. Pleomorphic adenoma was present in 9 cases; de-differentiation was seen in two patients. Immunohistochemical studies showed positive reactions for pan-cytokeratin, CK7, CK5/6, CAM5.2, and EMA, with myoepithelial reactivity with SMA, p63, calponin, S100 protein and SMMHC. CD117, CEA, GFAP and p16 were variably present. CK20 and HR HPV were negative. STACC needs to be considered in the differential diagnosis of most sinonasal malignancies, particularly poorly differentiated carcinoma, olfactory neuroblastoma and pleomorphic adenoma. Surgery (n = 82), often accompanied by radiation therapy (n = 36), was generally employed. A majority of patients developed a recurrence (n = 52) 2–144 months after initial presentation. Overall mean follow-up was 19.4 years (range 0.4–37.5 years): 46 patients died with disease (mean 6.4 years); 5 were alive with disease (mean 5.4 years), and 35 patients were either alive or had died of unrelated causes (mean 16.3 years). ACC of the SNT is uncommon. Recurrences are common. The following parameters, when present, suggest an increased incidence of either recurrence or dying with disease: mixed site of involvement, high stage disease (stage IV), skull base involvement, tumor recurrence, a solid histology, perineural invasion, bone invasion, and lymphovascular invasion.
The article of record as published may be found at http://dx.doi.org/10.1007/s12105-013-0487-3
Showing items related by title, author, creator and subject.
Condos, William Randolph, Jr.; Knox, Everett William (Monterey, California. Naval Postgraduate School, 1973-03);The objectives of this thesis were to design a method for evaluation of the diagnostic potential of available indicators of coronary heart disease (CHD) and to present a systematics, quantitative procedure to aiding in its ...
Regnier, Eva D.; Shechter, Steven M. (John Wiley & Sons, Ltd., 2013-04-23);Markov models of disease progression are widely used to model transitions in patients’ health state over time. Usually, patients’ health status may be classified according to a set of ordered health states. Modelers ...
Analysis of the distribution of vaccine using Department of Defense assets versus contracts with private-sector delivery companies Latta, Jason E. (Monterey, California. Naval Postgraduate School, 2009-12);It is not a question of "if" the next pandemic influenza outbreak will strike, but "when." The current plan for vaccine distribution that the Department of Defense (DoD) has in place is to extend contracts to civilian ...